18.10.2017
- As generics pricing pressure increases, Swiss drugmaker Novartis said it will close a US plant at Broomfield, Colorado, owned by its Sandoz subsidiary and employing 450 people. It...
11.10.2017
- Swiss specialty chemicals company Lonza has acquired Shire’s clinical-stage mammalian manufacturing site in Hayward, California, USA, boosting its cGMP capacity and supplementing...
22.09.2017
- US drugmaker Catalent has agreed to buy contract development and manufacturing organization (CDMO) Cook Pharmica for $950 million in cash, boosting its position in the fast-growing...
23.08.2017
- South Korean biopharmaceutical company Samsung Bioepis is taking its first step into novel drug development with an agreement to partner Japan’s Takeda Pharmaceutical. The move...
28.02.2017
- French drugmaker Sanofi and Swiss fine chemicals producer and toll manufacturing specialist Lonza plan to jointly invest in a new €270 million large-scale mammalian cell culture...
28.10.2016
- Catalent Pharma Solutions has broken ground on a $34 million extension to its biologics manufacturing facility in Madison, Wisconsin, USA. When completed, the additional 22,000...
02.09.2016
- During the last two decades the pharmaceutical industry was forced to undertake significant structural changes to address mounting challenges from strict regulatory policies, lower...
04.05.2016
- An R&D collaboration between Dublin, Ireland-based Nexvet Biopharma, a veterinary biologics developer, and Japanese animal health company Zenoaqa claims to have found fully...
